🇺🇸 FDA
Patent

US 10206921

Methods and compositions for treating a subject for central nervous system (CNS) injury

granted A61KA61K31/5025A61K31/551

Quick answer

US patent 10206921 (Methods and compositions for treating a subject for central nervous system (CNS) injury) held by The Regents of the University of California expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/5025, A61K31/551, A61K31/5517, A61K31/713